Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1987 7
1988 4
1989 8
1990 6
1991 7
1992 4
1993 8
1994 6
1995 8
1996 5
1997 5
1998 14
1999 13
2000 12
2001 8
2002 14
2003 10
2004 11
2005 10
2006 13
2007 12
2008 9
2009 12
2010 11
2011 9
2012 12
2013 15
2014 19
2015 24
2016 24
2017 18
2018 16
2019 19
2020 15
Text availability
Article attribute
Article type
Publication date

Search Results

359 results
Results by year
Filters applied: . Clear all
Page 1
Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders.
Devinsky O, Cilio MR, Cross H, Fernandez-Ruiz J, French J, Hill C, Katz R, Di Marzo V, Jutras-Aswad D, Notcutt WG, Martinez-Orgado J, Robson PJ, Rohrback BG, Thiele E, Whalley B, Friedman D. Devinsky O, et al. Among authors: fernandez ruiz j. Epilepsia. 2014 Jun;55(6):791-802. doi: 10.1111/epi.12631. Epub 2014 May 22. Epilepsia. 2014. PMID: 24854329 Free PMC article. Review.
Cannabinoid pharmacology/therapeutics in chronic degenerative disorders affecting the central nervous system.
Aymerich MS, Aso E, Abellanas MA, Tolon RM, Ramos JA, Ferrer I, Romero J, Fernández-Ruiz J. Aymerich MS, et al. Among authors: fernandez ruiz j. Biochem Pharmacol. 2018 Nov;157:67-84. doi: 10.1016/j.bcp.2018.08.016. Epub 2018 Aug 17. Biochem Pharmacol. 2018. PMID: 30121249 Free article. Review.
Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?
Fernández-Ruiz J, Sagredo O, Pazos MR, García C, Pertwee R, Mechoulam R, Martínez-Orgado J. Fernández-Ruiz J, et al. Br J Clin Pharmacol. 2013 Feb;75(2):323-33. doi: 10.1111/j.1365-2125.2012.04341.x. Br J Clin Pharmacol. 2013. PMID: 22625422 Free PMC article. Review.
Structure-Effect Relationships of Novel Semi-Synthetic Cannabinoid Derivatives.
Götz MR, Collado JA, Fernández-Ruiz J, Fiebich BL, García-Toscano L, Gómez-Cañas M, Koch O, Leha A, Muñoz E, Navarrete C, Pazos MR, Holzgrabe U. Götz MR, et al. Among authors: fernandez ruiz j. Front Pharmacol. 2019 Nov 20;10:1284. doi: 10.3389/fphar.2019.01284. eCollection 2019. Front Pharmacol. 2019. PMID: 31824305 Free PMC article.
Preface: Why a Special Issue on cannabinoid research in Spain?
Fernández-Ruiz J. Fernández-Ruiz J. Biochem Pharmacol. 2018 Nov;157:1-7. doi: 10.1016/j.bcp.2018.10.018. Epub 2018 Oct 21. Biochem Pharmacol. 2018. PMID: 30352232 No abstract available.
A double-blind, randomized, cross-over, placebo-controlled, pilot trial with Sativex in Huntington's disease.
López-Sendón Moreno JL, García Caldentey J, Trigo Cubillo P, Ruiz Romero C, García Ribas G, Alonso Arias MA, García de Yébenes MJ, Tolón RM, Galve-Roperh I, Sagredo O, Valdeolivas S, Resel E, Ortega-Gutierrez S, García-Bermejo ML, Fernández Ruiz J, Guzmán M, García de Yébenes Prous J. López-Sendón Moreno JL, et al. Among authors: fernandez ruiz j. J Neurol. 2016 Jul;263(7):1390-400. doi: 10.1007/s00415-016-8145-9. Epub 2016 May 9. J Neurol. 2016. PMID: 27159993 Clinical Trial.
Endocannabinoids and Neurodegenerative Disorders: Parkinson's Disease, Huntington's Chorea, Alzheimer's Disease, and Others.
Fernández-Ruiz J, Romero J, Ramos JA. Fernández-Ruiz J, et al. Handb Exp Pharmacol. 2015;231:233-59. doi: 10.1007/978-3-319-20825-1_8. Handb Exp Pharmacol. 2015. PMID: 26408163 Review.
VCE-004.3, a cannabidiol aminoquinone derivative, prevents bleomycin-induced skin fibrosis and inflammation through PPARγ- and CB2 receptor-dependent pathways.
Del Rio C, Cantarero I, Palomares B, Gómez-Cañas M, Fernández-Ruiz J, Pavicic C, García-Martín A, Luz Bellido M, Ortega-Castro R, Pérez-Sánchez C, López-Pedrera C, Appendino G, Calzado MA, Muñoz E. Del Rio C, et al. Among authors: fernandez ruiz j. Br J Pharmacol. 2018 Oct;175(19):3813-3831. doi: 10.1111/bph.14450. Epub 2018 Aug 23. Br J Pharmacol. 2018. PMID: 30033591 Free PMC article.
Benefits of VCE-003.2, a cannabigerol quinone derivative, against inflammation-driven neuronal deterioration in experimental Parkinson's disease: possible involvement of different binding sites at the PPARγ receptor.
García C, Gómez-Cañas M, Burgaz S, Palomares B, Gómez-Gálvez Y, Palomo-Garo C, Campo S, Ferrer-Hernández J, Pavicic C, Navarrete C, Luz Bellido M, García-Arencibia M, Ruth Pazos M, Muñoz E, Fernández-Ruiz J. García C, et al. Among authors: fernandez ruiz j. J Neuroinflammation. 2018 Jan 16;15(1):19. doi: 10.1186/s12974-018-1060-5. J Neuroinflammation. 2018. PMID: 29338785 Free PMC article.
Analysis of miRNA expression in patients with rheumatoid arthritis during remission and relapse after a 5-year trial of tofacitinib treatment.
Fernández-Ruiz JC, Ramos-Remus C, Sánchez-Corona J, Castillo-Ortiz JD, Castañeda-Sánchez JJ, Bastian Y, Romo-García MF, Ochoa-González F, Monsivais-Urenda AE, González-Amaro R, Enciso-Moreno JA, Castañeda-Delgado JE. Fernández-Ruiz JC, et al. Int Immunopharmacol. 2018 Oct;63:35-42. doi: 10.1016/j.intimp.2018.07.028. Epub 2018 Jul 31. Int Immunopharmacol. 2018. PMID: 30075427 Clinical Trial.
359 results
Jump to page
Feedback